Cubist Systematic Strategies’s Prelude Therapeutics PRLD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-40,102
| Closed | -$83K | – | 2136 |
|
2024
Q3 | $83K | Buy |
+40,102
| New | +$83K | ﹤0.01% | 1246 |
|
2023
Q2 | – | Sell |
-8,778
| Closed | -$50K | – | 2857 |
|
2023
Q1 | $50K | Buy |
+8,778
| New | +$50K | ﹤0.01% | 2521 |
|
2022
Q3 | – | Sell |
-39,938
| Closed | -$208K | – | 3834 |
|
2022
Q2 | $208K | Buy |
+39,938
| New | +$208K | ﹤0.01% | 3138 |
|
2022
Q1 | – | Sell |
-116,303
| Closed | -$1.45M | – | 3706 |
|
2021
Q4 | $1.45M | Buy |
116,303
+94,548
| +435% | +$1.18M | 0.01% | 1637 |
|
2021
Q3 | $680K | Buy |
21,755
+4,558
| +27% | +$142K | 0.01% | 1817 |
|
2021
Q2 | $492K | Buy |
17,197
+10,802
| +169% | +$309K | 0.01% | 2023 |
|
2021
Q1 | $277K | Buy |
+6,395
| New | +$277K | ﹤0.01% | 2302 |
|
2020
Q4 | – | Sell |
-100
| Closed | -$3K | – | 2679 |
|
2020
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2455 |
|